PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
23.90%
Net income growth under 50% of VET's 4634.58%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
14.03%
D&A growth well above VET's 0.78%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-128.58%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
No Data
No Data available this quarter, please select a different quarter.
901.37%
Well above VET's 107.82% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
901.37%
Growth well above VET's 107.82%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-33.01%
Both negative yoy, with VET at -84.18%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-4.41%
Negative yoy CFO while VET is 282.08%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-8.18%
Negative yoy CapEx while VET is 0.00%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
30.37%
Growth well above VET's 9.47%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
968.16%
Investing outflow well above VET's 9.47%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
97.25%
We slightly raise equity while VET is negative at -114.46%. John Neff sees competitor possibly preserving share count or buying back shares.
No Data
No Data available this quarter, please select a different quarter.